Cytotoxic and COX-2 inhibition properties of hydroxycinnamic derivatives

Letters in Drug Design and Discovery

Volumn 3, Issue 5, 2006, Pages 316-320

  Marques, M Paula M ^a,b   Borges, Fernanda ^a,c   Sousa, Joana ^a   Calheiros, Rita ^a   Garrido, Jorge ^a,d   Gaspar, Alexandra ^c   Antunes, Fernanda ^c   Diniz, Carmen ^c   Fresco, Paula ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

Author keywords

Anti inflammatory; Anticancer; COX 2; Hydroxycinnamic derivatives; Mammary gland adenocarcinoma cells

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; COUMARIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DIETHYL 2 (3,4,5 TRIHYDROXY PHENYLMETHYLENE)MALONATE; INDOMETACIN; TRANS 3 (3,4,5 TRIHYDROXYPHENYL) 2 PROPENOIC ACID; TRANS ETHYL(3,4,5 TRIHYDROXYPHENYL) 2 PROPENOATE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MAMMARY GLAND; PRIORITY JOURNAL;

EID: 33745603707     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006777574212     Document Type: Article

References (42)

1. Chung, W. -Y.; Jung, Y. J.; Surh, Y. J.; Lee, S. S.; Park, K. K. Mutat. Res. 2001, 496, 199.
2. Son, S.; Lewis, A. B. J. Agric. Food Chem. 2002, 50, 468.
3. Kikuzaki, H.; Hisamoto, M.; Hirose, K.; Akiyama, K.; Taniguchi, H. J. Agric. Food Chem. 2002, 50, 2161.
4. Nenadis, N.; Zhang, H. J.; Tsimidou, M. Z. J. Agric. Food Chem. 2003, 51, 1874.
5. Cai, Y.; Luo, Q.; Sun, L.; Corke, H. Life Sci. 2004, 74, 2157.
6. Esterbauer, H.; Gebicki, J.; Puhl, H.; Jurgens, G. Free Rad. Biol. Med. 1992, 13, 341.
7. Halliwell, B.; Gutteridge, J. C. "Free Radicals in Biology and Medicine", Oxford Science Publications, 1999.
8. Passi, S.; Picardo, M.; Nazzaro-Porro, M. Biochem. J. 1987, 245 , 537
9. Nakayama, T. Cancer Res. 1994, 54, 1991.
10. Sergediene, E.; Jonsson, K.; Szymusiak, H.; Tyrakowska, B.; Rietjens, I. M. C. M.; Cenas, N. FEBS Lett. 1999, 462, 392.
11. Inoue, M.; Sakaguchi, N.; Isuzugawa, K.; Tani, H.; Ogihara, Y. Biol. Pharm. Bull. 2000, 23, 1153.
12. Roy, G.; Lombardía, M.; Palacios, C.; Serrano, A.; Cespón, C.; Ortega, E.; Eiras, P.; Lujan, S.; Revilla, Y.; González- Porqué, P. Arch. Biochem. Biophys. 2000, 383, 206.
13. Gao, T.; Ci, Y.; Jian, H.; An, C. Vib. Spec. 2000, 24, 225.
14. Tapiero, H.; Tew, K. D.; Ba, G. N.; Mathe, G. Biomed. Pharmacother. 2002, 56, 200.
15. Gomes, C. A.; Girão da Cruz, M. T.; Andradre, J. L.; Milhazes, N.; Borges, F.; Marques, M. P. M. J. Med. Chem. 2003, 46, 5395.
16. Fiuza, S. M.; Gomes, C. A.; Teixeira, L. J.; Girão da Cruz, M. T.; Cordeiro, M. N. D. S.; Milhazes, N.; Borges, F.; Marques, M. P. M. Bioorg. Med. Chem. 2004, 12, 3581.
17. Nomura, M.; Kaji, A.; Ma, W.; Miyamoto, K.; Dong, Z. Mol. Carcinog. 2001, 31, 83.
18. Nagaoka, T.; Banskota, A. H.; Tezuka, Y.; Saiki, I.; Kadota, S. Bioorg. Med. Chem. 2002, 10, 3351.
19. Michaluart, P.; Masferrer, J. L.; Carothers, A. M.; Subbaramaiah, K.; Zweifell, B. S.; Koboldt, C.; Mestre, J. R.; Grunberger, D.; Sacks, P. G.; Tanabe, T.; Dannenberg, A. J. Cancer Res. 1999, 59, 2347.
20. Lin, J. K.; Shih, C. A. Carcinogenesis. 1994, 15, 1717.
21. Fresco P.; Borges F.; Diniz C.; Marques M. P. M. Med. Res. Rev. 2005, in press.
22. Tan, W. F.; Lin, L. P.; Li, M. H.; Zhang, Y. X.; Tong, Y. G.; Xiao, D.; Ding, J. Eur J. Pharmacol. 2003, 459, 255.
23. Fiander, H.; Schneider, H. Cancer Lett. 2000, 156, 117.
24. Gourley, M; Williamson, J. S. Curr. Pharm. Des. 2000, 6, 417.
25. Chen. C.; Kong, N. A. Free Radic. Biol. Med. 2004, 36, 1505.
26. Helliwell, R. J. A.; Adams L. F.; Mitchell, M. D. Prostanglandins Leukot. Essent. Fatty Acids 2004, 70, 101.
27. Konturek, P. C.; Kania, J.; Burnat, G.; Hahn, E. G.; Konturek, S. J. J. Physiol. Pharmacol. 2005, 56, 57.
28. Backlund, M. G.; Mann, J. R.; Dubois, R. N. Oncology. 2005, 69 (Suppl. 1), 28.
29. Romano, M.; Claria J. FASEB J., 2003, 17, 1986.
30. Fujimoto, J.; Toyoki, H.; Sakaguchi, H.; Jahan, I.; Alam, S. M.; Tamaya, T. Oncol Rep. 2006, 15, 21.
31. Rayyan, Y.; Williams, J.; Rigas, B. Cancer Invest. 2002, 20, 1002.
32. Subbaramaiah, K.; Lin, D. T.; Hart, J. C.; Dannenberg, A. J. J. Biol. Chem. 2001, 276, 12440.
33. Freudenberg K.; Hubner H. H. Chem. Ber. 1952, 85, 1181.
34. Nakayama, G. R.; Caton, M. C.; Nova, M. P.; Parandoosh, Z. J. Immunol. Methods 1997, 204, 205.
35. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Eur. J. Biochem. 2000, 267, 5421.
36. Xie, W.; Chipman, J. G.; Robertson, D. L.; Erikson, R. L.; Simmons, D. L. Proc Natl Acad Sci USA 1991, 88, 2692.
37. Parvataneni R.; Rao, P. R.; Archana J.; Rao, N. K. Biol. Pharm. Bull. 2005, 28, 1311.
38. Rio, V.; Siquet, C.; Sousa J. B.; Reis S.; Marques M. P. M.; Borges, F. 2005 submitted.
39. Sousa, J. B.; Calheiros, R.; Rio, V.; Borges F.; Marques, M. P. M. J. Mol. Struct. 2006, 783, 122.
40. Fiuza S. M.; Van Besien E.; Milhazes N.; Borges F.; Marques M. P. M. J. Mol. . Struct. 2004, 693, 103.
41. Siquet, C.; Paiva-Martins, F.; Lima, J. L. F. C.; Reis, S.; Borges, F. Free Radic. Res. 2006, 40 (4), 433-442.
42. Silva F. A. M.; Borges F.; Guimarães C.; Lima J. L. F. C.; Matos C.; Reis S. J. Agric. Food Chem. 2000, 48, 2122.